Global Tumor Ablation Market is expected to reach $1,253.33 million by 2027 growing at a CAGR 13.7% during 2018 to 2027.

VCNN Editor Avatar

Some of the key players in global tumor ablation market are INTIO Inc., Medtronic PLC, Galil Medical, Inc., Sonacare Medical, Koninklijke Philips N.V, Misonix, Inc., IceCure Medical Ltd., and B V M Meditech Private Limited.

Gaithersburg, Maryland, United States – April 17, 2020 /MarketersMedia/

Some of the key factors influencing the market growth include technological advancements in the thermal ablation techniques, growing geriatric population across the world, increasing incidence of cancer and sprouting number of hospitals, surgical, and ablation centres. However, the strict regulatory process is restraining market growth.

Request for sample here: https://www.strategymrc.com/report/Tumor-Ablation-Market/request-sample

Tumor ablation is a minimally invasive image-guided technique used in the treatment of the tumors in the liver, kidney, soft tissue and bone. It ensures high efficacy of tumor treatment with minimal side effects by using heat, chemicals and low temperature. It uses an array of parallel alternating electrodes to deliver radiofrequency energy that heats the lining of the gastrointestinal tract, destroying the cancerous or infected tissue. Tumor ablation has primarily been used for the treatment of oesophagal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia.

Based on the technology, radiofrequency ablation system (RFA) is expected to grow at a significant rate during the forecast period, due to its ease of treatment (as compared to open surgical procedure), its proven clinical efficacy and safety profile, and ongoing developments & commercialization of technologically advanced radiofrequency tumor ablation systems. Radiofrequency ablation uses high-energy radio waves for treatment, in which a thin, needle-like probe is inserted into the tumor. RFA is more effective in hepatocellular carcinoma (HCC), the most common primary liver neoplasia with a poor diagnosis.

Access the complete report at: https://www.strategymrc.com/report/Tumor-Ablation-Market

By geography, North America is likely to have a huge demand owing to high prevalence and incidence of major types of cancer (such as liver, lung, kidney, and bone metastasis) in the region, rising inclination of patients towards minimally invasive procedures for cancer treatment, and increasing government funding for cancer research. The growing investments of many key players in this market have grown significantly in the United States. Besides, the focus on the development of products with innovative features and greater effectiveness has increased in recent times. As a result, there has been a rise in R&D funds.

Make an inquiry at: https://www.strategymrc.com/report/Tumor-Ablation-Market

Treatments Covered:
• Laparoscopic ablation
• Surgical ablation
• Percutaneous ablation

Functions Covered:
• Conventional ablation devices
• Automated/Robotic ablation

Technologies Covered:
• Image Guidance Products
• Tumor Ablation Systems
• Catheters or Probes

Applications Covered:
• Liver cancer
• Prostate cancer
• Lung cancer
• Breast cancer
• Kidney cancer
• Bone Metastasis
• Brain Cancer
• Pancreatic Cancer
• Pain palliation
• ENT Cancer

End Users Covered:
• Oncology Clinics
• Research Institutes
• Cancer Specialty Centers
• Hospitals
• Surgical and Ablation Centers
• Diagnostic Centres

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 9 years of all the mentioned segments, sub-segments, and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

Follow us on Twitter: https://twitter.com/StratisticsMRC

Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile

About Stratistics MRC
We offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services, and Full-Time Equivalent (FTE) services in the research world. We explore market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.

Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.

Contact Info:
Name: James Lamb
Email: Send Email
Organization: Stratistics Market Research Consulting Pvt Ltd
Phone: +1-301-202-5929
Website: https://www.strategymrc.com/

Source URL: https://marketersmedia.com/global-tumor-ablation-market-is-expected-to-reach-125333-million-by-2027-growing-at-a-cagr-137-during-2018-to-2027/88953964

Source: MarketersMedia

Release ID: 88953964

VCNN Editor Avatar
Search
Categories